Clinical Trials in California

Showing 3201-3220 of 5,448 trials

Single-Use Negative Pressure Wound Therapy System vs. Traditional Negative Pressure Wound Therapy System (tNPWT)

NCT02470806

The aim of this study is to compare the clinical efficacy of two types of NPWT systems; the traditional negative pressure wound therapy (tNPWT) system and the single-use negative pressure wound therapy (PICO) system.

Venous Leg UlcersDiabetic Foot Ulcers

Smith & Nephew, Inc.164 participantsStarted Jul 2015

Carlsbad, California, United States • Fresno, California, United States • Martinez, California, United States +14 more locations

COMPLETEDPhase 344 miles

Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin

NCT02963922

This trial is conducted globally. The aim of this trial is to investigate effect and safety of liraglutide 3.0 mg in subjects with overweight or obesity and type 2 diabetes mellitus treated with basal insulin.

Metabolism and Nutrition DisorderObesity

Novo Nordisk A/S396 participantsStarted Feb 2017

Birmingham, Alabama, United States • Concord, California, United States • Fresno, California, United States +51 more locations

Single-Use Negative Pressure Wound Therapy System vs. Traditional Negative Pressure Wound Therapy System (tNPWT)

Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin

Find Trials by Condition in California

Lung-MAP: Rilotumumab and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches

Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer

Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke

Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps

Ofatumumab Bendamustine Combination Compared With Bendamustine Monotherapy in Indolent B-cell NHL Unresponsive to Rituxtherapy

VITROS Immunodiagnostic Products NT-proBNP II

A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab

Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome

TIME Study: Therapeutic Hypothermia for Infants With Mild Encephalopathy

Novel Endoluminal Clinical TreAtment of Reflux

Peanut Oral Immunotherapy in Children

ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain

ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa

A Study of B-701 in Combination With Pembrolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma

Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer

Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery

Single-Ascending-Dose Study of BIIB076 in Healthy Volunteers and Participants With Alzheimer's Disease